InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Foundation Fighting Blindness Retinal Degeneration Fund. Director active across 1 company, notably Opus Genetics, Inc.. Aggregated, 2 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €7.4m. History available since 9 December 2025. The latest transaction was filed on 9 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations